The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients

Transplant International

Volumn 21, Issue 9, 2008, Pages 857-866

  Kantola, Taru ^a,b   Koivusalo, Anna Maria ^a   Höckerstedt, Krister ^a   Isoniemi, Helena ^a  

^a Surgical Hospital   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute liver failure; Liver transplantation; Molecular adsorbent recirculating system; Survival

Indexed keywords

ADULT; ALBUMIN DIALYSIS; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; GRAFT SURVIVAL; HEPATIC ENCEPHALOPATHY; HUMAN; IDIOPATHIC DISEASE; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ACETAMINOPHEN; ADULT; ANALGESICS, NON-NARCOTIC; FEMALE; FINLAND; HUMANS; INTENSIVE CARE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES;

EID: 49649128643     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00698.x     Document Type: Article

References (39)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970 3 : 282.
2. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993 342 : 273.
3. Ellis A, Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 1996 16 : 379.
4. Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990 11 : 49.
5. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996 16 : 389.
6. Tessier G, Villeneuve E, Villeneuve JP. Etiology and outcome of acute liver failure: experience from a liver transplantation centre in montreal. Can J Gastroenterol 2002 16 : 672.
7. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the united states. Liver Transpl Surg 1999 5 : 29.
8. Lee WM. Acute liver failure in the united states. Semin Liver Dis 2003 23 : 217.
9. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the united states. Ann Intern Med 2002 137 : 947.
10. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004 10 : 1018.
11. O'grady J. Modern management of acute liver failure. Clin Liver Dis 2007 11 : 291.
12. Scandiatransplant. Scandiatransplant - A Nordic Organ Exchange Organization [homepage on the Internet]. University Hospital Skejby in Aarhus, Denmark : Scandiatransplant. 2007 Available at http://www.scandiatransplant.org, accessed 1 March, 2007.
13. The European Liver and Intestinal Transplant Association (ELITA). European Liver Transplant Registry [homepage on the Internet]. 2006 Available at http://www.ELTR.org, accessed 1 December, 2006.
14. Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. ASAIO J 1993 39 : M621.
15. Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993 17 : 809.
16. Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. safety barrier between a patients blood and a bioartificial liver. Int J Artif Organs 1996 19 : 677.
17. Brandsaeter B, Hockerstedt K, Friman S, et al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation - 12 years experience in the Nordic countries. Liver Transpl 2002 8 : 1055.
18. Koivusalo AM, Yildirim Y, Vakkuri A, Lindgren L, Hockerstedt K, Isoniemi H. Experience with albumin dialysis in five patients with severe overdoses of paracetamol. Acta Anaesthesiol Scand 2003 47 : 1145.
19. Lahdenpera A, Koivusalo AM, Vakkuri A, Hockerstedt K, Isoniemi H. Value of albumin dialysis therapy in severe liver insufficiency. Transpl Int 2005 17 : 717.
20. United Network for Organ Sharing (UNOS). MELD/PELD Calculators [homepage on the Internet]. 2008 Available at http://www.unos.org/resources/ MeldPeldCalculator.asp?index=98, accessed 6 January, 2008.
21. Kremers WK, van IJperen M, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004 39 : 764.
22. Freeman RB Jr., Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant 2004 4 (Suppl. 9 114.
23. Felldin M, Friman S, Olausson M, et al. Liver dialysis using MARS in acute hepatic failure. promising results in a pilot setting. Lakartidningen 2003 100 : 3836, 8, 3841.
24. Lee KH, Lee MK, Sutedja DS, Lim SG. Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure. Liver Int 2005 25 : 973.
25. Doria C, Mandala L, Scott VL, Gruttadauria S, Marino IR. Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience. Dig Dis Sci 2006 51 : 47.
26. Camus C, Lavoue S, Gacouin A, et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 2006 32 : 1817.
27. Wai CT, Lim SG, Aung MO, et al. MARS: a futile tool in centres without active liver transplant support. Liver Int 2007 27 : 69.
28. Bernal W. Changing patterns of causation and the use of transplantation in the united kingdom. Semin Liver Dis 2003 23 : 227.
29. Khashab M, Tector AJ, Kwo PY. Epidemiology of acute liver failure. Curr Gastroenterol Rep 2007 9 : 66.
30. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a united states multicenter, prospective study. Hepatology 2005 42 : 1364.
31. O'Grady JG, Williams R. Acute liver failure. Baillieres Clin Gastroenterol 1989 3 : 75.
32. Polson J, Lee WM, American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005 41 : 1179.
33. Schiodt FV, Lee WM. Liver transplantation for acute liver failure - better safe than sorry. Liver Transpl 2002 8 : 1063.
34. Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000 6 : 277.
35. El Banayosy A, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R. First use of the molecular adsorbent recirculating system technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J 2004 50 : 332.
36. Heemann U, Treichel U, Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002 36 (4 Pt 1 949.
37. Sen S, Mookerjee RP, Davies NA, Williams R, Jalan R. Review article: the molecular adsorbents recirculating system (MARS) in liver failure. Aliment Pharmacol Ther 2002 16 (Suppl. 5 32.
38. Tan HK. Molecular adsorbent recirculating system (MARS). Ann Acad Med Singapore 2004 33 : 329.
39. Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl 2004 10 : 1099.